<?xml version="1.0" encoding="UTF-8"?>
<p id="Par27">The ability to capture unique epigenomic alterations associated with PD remains an important challenge. Reprogramming fibroblasts to iPSCs may erase age-associated
 <sup>
  <xref ref-type="bibr" rid="CR225">225</xref>
 </sup> and naive epigenetic signatures which could contribute to sporadic PD pathophysiology
 <sup>
  <xref ref-type="bibr" rid="CR226">226</xref>
 </sup>. However, an epigenetic phenotype was reported in iPSC-derived PD patient neurons
 <sup>
  <xref ref-type="bibr" rid="CR79">79</xref>,
  <xref ref-type="bibr" rid="CR89">89</xref>
 </sup>. Neuronal lines derived from LRRK2 and sporadic patients exhibited epigenomic alterations when compared with healthy controls
 <sup>
  <xref ref-type="bibr" rid="CR79">79</xref>
 </sup>. Hypermethylation was prominent in gene regulatory regions associated with the downregulation of transcription factors FOXA1, NR3C1, HNF4A, and FOSL2
 <sup>
  <xref ref-type="bibr" rid="CR79">79</xref>
 </sup>. Interestingly, 
 <italic>LRRK2</italic> mutant and sporadic PD patient neurons shared similar methylation patterns, which were absent in the original donor fibroblasts
 <sup>
  <xref ref-type="bibr" rid="CR79">79</xref>
 </sup>. A spontaneous increase in the number of DNA strand breaks and genomic damage
 <sup>
  <xref ref-type="bibr" rid="CR89">89</xref>
 </sup> in PD patient-derived neurons could indirectly impact genomic regulation.
</p>
